Compare Wockhardt with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ALEMBIC LTD - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ALEMBIC LTD WOCKHARDT/
ALEMBIC LTD
 
P/E (TTM) x -20.1 70.6 - View Chart
P/BV x 1.1 2.5 42.3% View Chart
Dividend Yield % 0.0 0.4 0.9%  

Financials

 WOCKHARDT   ALEMBIC LTD
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
ALEMBIC LTD
Mar-18
WOCKHARDT/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,01272 1,405.6%   
Low Rs53234 1,567.8%   
Sales per share (Unadj.) Rs355.94.7 7,570.6%  
Earnings per share (Unadj.) Rs-60.36.1 -987.6%  
Cash flow per share (Unadj.) Rs-46.86.2 -748.8%  
Dividends per share (Unadj.) Rs0.010.20 5.0%  
Dividend yield (eoy) %00.4 0.3%  
Book value per share (Unadj.) Rs257.840.7 634.0%  
Shares outstanding (eoy) m110.63267.03 41.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.211.3 19.3%   
Avg P/E ratio x-12.88.7 -147.6%  
P/CF ratio (eoy) x-16.58.5 -194.7%  
Price / Book Value ratio x3.01.3 229.9%  
Dividend payout %03.3 -0.5%   
Avg Mkt Cap Rs m85,37914,139 603.8%   
No. of employees `0006.3NA-   
Total wages/salary Rs m9,371207 4,518.1%   
Avg. sales/employee Rs Th6,295.0NM-  
Avg. wages/employee Rs Th1,498.3NM-  
Avg. net profit/employee Rs Th-1,066.3NM-  
INCOME DATA
Net Sales Rs m39,3691,255 3,136.5%  
Other income Rs m1,202370 324.8%   
Total revenues Rs m40,5711,625 2,496.1%   
Gross profit Rs m18111 16.5%  
Depreciation Rs m1,49538 3,955.8%   
Interest Rs m2,5552 150,288.2%   
Profit before tax Rs m-2,830442 -640.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m25724 1,073.1%   
Profit after tax Rs m-6,6691,630 -409.1%  
Gross profit margin %08.9 0.5%  
Effective tax rate %-9.15.4 -167.5%   
Net profit margin %-16.9129.8 -13.0%  
BALANCE SHEET DATA
Current assets Rs m33,7961,867 1,810.1%   
Current liabilities Rs m26,917591 4,553.0%   
Net working cap to sales %17.5101.6 17.2%  
Current ratio x1.33.2 39.8%  
Inventory Days Days7994 84.2%  
Debtors Days Days8974 121.3%  
Net fixed assets Rs m39,6641,791 2,214.8%   
Share capital Rs m553534 103.6%   
"Free" reserves Rs m27,96810,324 270.9%   
Net worth Rs m28,52210,858 262.7%   
Long term debt Rs m21,73141 52,745.4%   
Total assets Rs m81,62011,591 704.2%  
Interest coverage x-0.1260.9 -0.0%   
Debt to equity ratio x0.80 20,079.4%  
Sales to assets ratio x0.50.1 445.4%   
Return on assets %-5.014.1 -35.8%  
Return on equity %-23.415.0 -155.8%  
Return on capital %-7.715.2 -50.5%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m9,80719 50,552.1%   
Fx outflow Rs m1,789264 678.0%   
Net fx Rs m8,019-244 -3,280.6%   
CASH FLOW
From Operations Rs m684236 290.2%  
From Investments Rs m6,302-224 -2,813.6%  
From Financial Activity Rs m-7,695-27 28,927.4%  
Net Cashflow Rs m-664-15 4,486.5%  

Share Holding

Indian Promoters % 74.5 64.0 116.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.2 1,150.0%  
FIIs % 7.7 9.7 79.4%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 26.1 59.0%  
Shareholders   67,757 54,701 123.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   PROCTER & GAMBLE HEALTH  CIPLA  TORRENT PHARMA  SUVEN LIFESCIENCES  STERLING BIOTECH  

Compare WOCKHARDT With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Oct 22, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS